.
Winners of the Bridge Network Invention of the Year Awards, presented at UCC, are Prof. Cian O’Mathuna (Tyndall) for market-leading magnetics techology to improve battery life of mobile devices, Michael Lucey, Partner at Purdy Lucey Intellectual Property (sponsor) and Invention of the Year Award Winner Dr. Helena McMahon (IT Tralee) for her anti-skin ageing innovation, NutraECM. Photo: Cathal Noonan
INNOVATIONS that solve key challenges in today’s society from cancer diagnostics, skin ageing, mobile battery life to neonate vaccinations were among the winners of the prestigious Bridge Network Invention of the Year 2018 awards hosted by University College Cork this week.
The IT Tralee, Invention of the Year was won by Dr. Helena McMahon and team for their solution to address intrinsic or extrinsic skin ageing through extracellular matrix (ECM) production
The annual Bridge Network Invention of the Year awards showcase the most innovative research and inventions in technology across agritech, life sciences, biotechnology and ICT sectors.
Continued below…
.
As the largest technology transfer consortium in Ireland, the Bridge Network brings together researchers and innovators from University College Cork, Cork Institute of Technology, Teagasc and the Institute of Technology Tralee, to support the commercialisation of research.
Winners of the Bridge Network Invention of the Year Awards, presented at UCC, are Prof. Cian O’Mathuna (Tyndall) for market-leading magnetics techology to improve battery life of mobile devices, Kieran Meade (Teagasc) for his neonatal next generation vaccine invention and Aleksandra Augustyniak (IT Tralee) for NutraECM,an anti-skin ageing innovation.
Photo: Cathal Noonan
The IT Tralee, Invention of the Year was awarded to Dr. Helena McMahon and Dr. Aleksandra Augustyniak for the NutraECM solution, which has the potential to change how we treat skin ageing in the future and provide the ultimate solution to this issue.
NutraECM is an oral and topical treatment addressing intrinsic or extrinsic skin ageing, targeting collagen and elastin production, boosting dermal fibroblast proliferation and extracellular matrix (ECM) production. The solution has applicability not only for skin, but potentially also in cartilage and bone, where extracellular matrix is required.
